Biologic Videos

  1. Developability Assessment And Early Formulation Studies 1/26/2026

    Early developability and pre‑formulation screening build strong biophysical data, reduce late‑stage risks, support candidate selection, and streamline biologics development toward clinical success.

  2. AUC As An Alternative For Biologics, Gene Therapy Characterization 1/26/2026

    Learn how Analytical Ultracentrifugation enables detailed characterization of biologics, vaccines, and gene therapy vectors, offering a powerful alternative for R&D and emerging QC needs.

  3. Discover Our DNA-Encoded Library (DEL) Technology 1/26/2026

    Discover how DNA barcoding enables rapid screening of vast chemical space in early drug discovery, as well as how DEL platforms test billions of compounds efficiently.

  4. What Are The Benefits Of Combing AI And DELs For Drug Discovery? 1/26/2026

    Discover how AI-powered modeling uncovers hidden patterns in DEL data, broadens chemical diversity, and accelerates decision-making to help teams prioritize compounds and move more efficiently.

  5. Next-Level Cell Lines: An Integrated Approach To Biologic Innovation 1/22/2026

    See how AI-driven tools and optimized platforms are accelerating biologics development, delivering high-titer clones in weeks, and paving the way for integrated design of cell lines and genetic systems.

  6. Choosing The Right CDMO Partner In Biopharma 1/15/2026

    Selecting a CDMO is a high-stakes strategic decision impacting quality, timelines, and regulatory success. The right partner offers integrated capabilities, scientific expertise, agility, transparency, innovation, and shared purpose.

  7. How In-House CDMO Analytics Reduce Risk and Cost 1/15/2026

    Explore why integrated analytics within CDMOs is transforming biopharma: reducing risk, speeding timelines, ensuring data integrity, and preventing costly failures through seamless manufacturing and testing collaboration.

  8. Audiopost: From Research Stage To GMP Production 1/15/2026

    Discover the critical shift from flexible research to rigid GMP manufacturing, shaped by historic tragedies, strict regulations, and uncompromising standards—all to ensure medicine safety and patient trust.

  9. Optimized ADC Solutions Tailored To The Diverse Needs Of Global Clients 1/15/2026

    Accelerate the development of next-generation cancer therapies with optimized ADC solutions designed to meet the diverse needs of global clients.

  10. Beyond Geographies — Derisking Global Manufacturing 1/15/2026

    Gain expert insights on mitigating risks in global pharmaceutical manufacturing by learning from Joon Chang and Tracey Partington’s decades of industry experience.